-
5 days ago | 
blog.tipranks.com | Catie Powers
There’s a lot to be optimistic about in the Communication Services sector as 2 analysts just weighed in on Netflix (NFLX – Research Report) and Pinterest (PINS – Research Report) with bullish sentiments. Netflix (NFLX)In a report released today, James Heaney CFA from Jefferies maintained a Buy rating on Netflix, with a price target of $1400.00. The company’s shares closed last Monday at $1218.98.
-
5 days ago | 
mamamia.com.au | Catie Powers
"Especially in a deep plane lift, just under that deep plane are all the nerves, they're called the facial nerve, that work the muscles of facial expression," the plastic surgeon explained. "So every time you smile, crinkle your eyes, wriggle your nose, those are called the muscles of facial expression. And the nerves that motor those muscles are directly underneath the layer we're lifting."Any damage to the facial nerve could lead to "temporary or permanent problems with facial expression".
-
6 days ago | 
mamamia.com.au | Catie Powers
When Susan told the man that she had loose skin that could only be corrected through surgery, he was taken aback, but not unsupportive. "That scared me, because I worry he might be negatively surprised when he sees the reality," she told Mamamia.
-
1 week ago | 
mamamia.com.au | Catie Powers
For Jane, the relationship followed a cycle of love and punishment that kept her hoping things would improve. "If he felt lonely or down, he'd be all over me. He had these patterns. Certain days, I just knew he would be out drinking and coming home in a state.
-
1 week ago | 
blog.tipranks.com | Catie Powers
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on TransMedics Group (TMDX – Research Report) and Merck & Company (MRK – Research Report). TransMedics Group (TMDX) The company’s shares closed last Friday at $127.12. According to TipRanks.com, Jennings is a 4-star analyst with an average return of 4.2% and a 51.1% success rate.
-
1 week ago | 
mamamia.com.au | Catie Powers
"You would have flown them over and live in your home. What's the difference? And so the cognitive dissonance that I started to see even within my own family and my close circle, the community that I felt so comfortable in, I just couldn't reconcile," she said. The breaking point. Leah's breaking point came when some members of her church attended the January 6th Capitol riots.
-
1 week ago | 
blog.tipranks.com | Catie Powers
Alkyl Amines Chemicals Limited (NSE: ALKYLAMINE) has declared, under its dividend policy, a yearly cash dividend in the amount of 10.00 INR per common share. The dividend will be payable on 07/31/2025, to holders of record at the close of business on 06/24/2025. ALKYLAMINE has a dividend yield of 0.51%. Visit Tipranks’ unique Dividend Calendar to explore more dividend announcement dates and investment opportunities today!
-
1 week ago | 
mamamia.com.au | Catie Powers
For years, Gigi and Bella Hadid have walked red carpets side by side, inseparable, stunning, and undeniably close. Fashion's golden sisters, raised in the spotlight and admired around the world, their bond seemed unshakeable and complete. But what the world, and even Gigi and Bella, didn't know was that somewhere else, far from the flash of cameras and catwalks, there was another sister, named Aydan Nix. Now, they have revealed her to the world.
-
1 week ago | 
mamamia.com.au | Catie Powers
"What if this wasn't picked up? What if your heart stopped? What if that happened in front of your daughter, Lucy?" Jane recalled thinking. Quickly, she realised she had to make a change. She had been working herself to death, and needed to slow down. "It's not really logical that it was the stress and the overwork that got me to that state, because you would think that would lead to high blood pressure and a fast heart rate. But, that was the wake-up call," Jane said. "I thought, 'No, it's no good.
-
1 week ago | 
blog.tipranks.com | Catie Powers
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lexeo Therapeutics, Inc. (LXEO – Research Report), Immunovant (IMVT – Research Report) and Roivant Sciences (ROIV – Research Report). Lexeo Therapeutics, Inc. (LXEO)In a report issued on May 28, Mani Foroohar from Leerink Partners reiterated a Buy rating on Lexeo Therapeutics, Inc., with a price target of $10.00. The company’s shares closed last Thursday at $2.87, close to its 52-week low of $2.32.
